Sign in
4

Changes in Ownership

Viking Therapeutics, Inc. Filed Acc 0001209191-22-001987

Chief Operating Officer gave up 15,764 shares (to pay taxes)

  • Chief Operating Officer acquired 77,333 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Mancini Marianna · Chief Operating Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2022-01-03 Shares withheld for taxes : show line 1 in the form −3,919 $4.88 $19,125 174,034 D
2022-01-03 Grant or award : show line 2 in the form +77,333 251,367 D
2022-01-04 Shares withheld for taxes : show line 3 in the form −11,845 $4.62 $54,724 239,522 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-01-03 Grant or award : show line 4 in the form Stock Option (Right to Buy) +174,000 174,000 D
Loading xslF345X03/doc4.xml…